Skip to main content
Explore URMC
menu

Angela Branche, M.D.

Contact Information

Phone Numbers

Appointment: (585) 273-0526

Office: (585) 273-4104

Fax: (585) 442-9328

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentAccepting New Patients

Faculty Appointments

Patient Care Setting

Infectious Diseases

Biography

Professional Background

Dr. Branche is an Associate Professor of Medicine at the University of Rochester. She received her Bachelor of Arts degree in Biology at the University of Pennsylvania and Doctorate in Medicine at American University of the Caribbean. She completed residency in Internal Medicine at NYU Lutheran in Brooklyn, NY and infectious disease fellowship at the University of Rochester. She currently has a clinical inpatient practice comprised of both general infectious diseases and HIV medicine patients. Dr. Branche is also a New York State designated HIV/AIDS provider and has a practice comprised of adult patients ages 18 and older at the URMC HIV Clinic.

Research

During her years at the University of Rochester her focus in research involved the use of viral molecular and immunological diagnostic assays to explore the pathogenesis and host response to acute viral respiratory illnesses in adults. She is currently the Co-Principle Investigator for the UR Vaccine Treatment and Evaluation Unit (UR VTEU). Her current research activities explore clinical disease, pathogenesis, development of therapeutics and vaccine biology related to infection with viral and bacterial respiratory pathogens. Studies include assessment of asymptomatic carriage of Streptococcus pneumoniae and the impact of pneumococcal vaccination, surveillance of epidemic influenza infections and immunologic mechanisms of protection following natural infection versus vaccination, the development of pandemic influenza vaccines, population-based studies of RSV infection and the development of vaccine and anti-viral agents for RSV. Current efforts also include the study of the pathogenesis and immune response to pandemic SARS Coronavirus 2 infections and clinical interventional trials for the development of COVID19 therapeutic agents and vaccines. She is a member of the Infectious Disease Society of America and the NIH Human Cohorts Steering Committee and NIH IDCRC Emerging Infectious Expert Working Group. Dr. Branche has published several peer-reviewed articles, reviews and book chapters related to respiratory viral pathogens in adults.

Credentials

Specialties

  • Infectious Disease - American Board of Internal Medicine
  • Internal Medicine - American Board of Internal Medicine

Education

2007
MD | American University of the Caribbean

Post-doctoral Training & Residency

07/01/2012 - 06/30/2014
Fellowship in Infectious Disease at University of Rochester Medical Center

07/01/2009 - 06/30/2011
Residency in Internal Medicine at Lutheran Medical Center

07/01/2008 - 06/30/2009
Internship in Internal Medicine at Lutheran Medical Center

VIEW ALL expand_more

Publications

Journal Articles

12/10/2021
Ganaie F, Branche AR, Peasley M, Rosch JW, Nahm MH. "Oral streptococci expressing pneumococci-like cross-reactive capsule types can affect WHO recommended pneumococcal carriage procedure." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.. 2021 Dec 10; Epub 2021 Dec 10.

11/30/2021
Peterson DR, Baran AM, Bhattacharya S, Branche AR, Croft DP, Corbett AM, Walsh EE, Falsey AR, Mariani TJ. "Gene Expression Risk Scores for COVID-19 Illness Severity." The Journal of infectious diseases.. 2021 Nov 30; Epub 2021 Nov 30.

10/18/2021
Kalil AC, Mehta AK, Patterson TF, Erdmann N, Gomez CA, Jain MK, Wolfe CR, Ruiz-Palacios GM, Kline S, Regalado Pineda J, Luetkemeyer AF, Harkins MS, Jackson PEH, Iovine NM, Tapson VF, Oh MD, Whitaker JA, Mularski RA, Paules CI, Ince D, Takasaki J, Sweeney DA, Sandkovsky U, Wyles DL, Hohmann E, Grimes KA, Grossberg R, Laguio-Vila M, Lambert AA, Lopez de Castilla D, Kim E, Larson L, Wan CR, Traenkner JJ, Ponce PO, Patterson JE, Goepfert PA, Sofarelli TA, Mocherla S, Ko ER, Ponce de Leon A, Doernberg SB, Atmar RL, Maves RC, Dangond F, Ferreira J, Green M, Makowski M, Bonnett T, Beresnev T, Ghazaryan V, Dempsey W, Nayak SU, Dodd L, Tomashek KM, Beigel JH, . "Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial." The Lancet. Respiratory medicine.. 2021 Oct 18; Epub 2021 Oct 18.

VIEW ALL PUBLICATIONS